Abstract
Wasabi nose, a term used to describe the nasopharyngeal discomfort experienced during cyclophosphamide infusions, is a rare phenomenon, previously described in case reports of adult oncology patients typically receiving high-dose chemotherapy regimens. The underlying mechanism by which this phenomenon occurs is unknown. We report four cases of children with rheumatic diseases afflicted by profound nasopharyngeal discomfort secondary to low-dose cyclophosphamide infusions. We additionally review the literature regarding potential medical management of these complications and describe our experience using these interventions.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1003-1005 |
| Number of pages | 3 |
| Journal | Clinical Rheumatology |
| Volume | 30 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2011 |
Keywords
- Cyclophosphamide
- Drug toxicity
- Pediatric rheumatology
- Systemic lupus erythematosus
ASJC Scopus subject areas
- Rheumatology
Fingerprint
Dive into the research topics of 'Wasabi nose: An underreported complication of cyclophosphamide infusions'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS